U.S. Markets closed

How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs

Ron Leuty
How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs

After its acquisition of Warp Drive Bio last year, this Redwood City biotech company took its cancer-fighting trek into the "undruggable" universe.